Teresa Longobardi1, Charles N Bernstein. 1. University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre and Department of Medicine, Winnipeg, Manitoba, Canada.
Abstract
BACKGROUND & AIMS: The aim of this study was to quantify temporal changes in health care utilization by a population-based cohort of IBD. METHODS: By using the University of Manitoba IBD Epidemiology Database we assessed utilization of outpatient and hospital services, estimating relative risk (RR) of utilization for IBD cases compared with a matched cohort of non-IBD controls and for CD versus UC. We tested differences in utilization between prevalence cohorts 1990-1991 and 2000-2001. Also, utilization of the 1987-1988 incidence cohort was followed forward 15 years from diagnosis. The probability, intensity, and volume of utilization were estimated. RESULTS: In 2000-2001, IBD patients compared with controls were more likely to have an outpatient visit (RR, 1.18; 95% confidence interval [CI], 1.17-1.19) and an overnight hospital stay (RR, 2.32; 95% CI, 2.16-2.49). CD cases were more likely than UC cases to be hospitalized (RR, 1.26; 95% CI, 1.11-1.43) and had a greater number of outpatient visits. From 1990-1991 to 2000-2001, IBD cases experienced a significant decrease in the likelihood of an outpatient surgical visit relative to non-IBD controls (P < .05), and for those cases who were hospitalized, CD cases tended to be less likely than UC cases to experience IBD-specific inpatient surgery (P < .07). Of the 1987-1988 incidence cohort, 80% of admissions that occurred during the follow-up period were during the first 5 years after diagnosis. CONCLUSIONS: In 2000-2001, health care utilization continued to be higher in IBD versus controls and CD versus UC; however, the gap in costly service utilization appeared to narrow between the latter pair.
BACKGROUND & AIMS: The aim of this study was to quantify temporal changes in health care utilization by a population-based cohort of IBD. METHODS: By using the University of Manitoba IBD Epidemiology Database we assessed utilization of outpatient and hospital services, estimating relative risk (RR) of utilization for IBD cases compared with a matched cohort of non-IBD controls and for CD versus UC. We tested differences in utilization between prevalence cohorts 1990-1991 and 2000-2001. Also, utilization of the 1987-1988 incidence cohort was followed forward 15 years from diagnosis. The probability, intensity, and volume of utilization were estimated. RESULTS: In 2000-2001, IBD patients compared with controls were more likely to have an outpatient visit (RR, 1.18; 95% confidence interval [CI], 1.17-1.19) and an overnight hospital stay (RR, 2.32; 95% CI, 2.16-2.49). CD cases were more likely than UC cases to be hospitalized (RR, 1.26; 95% CI, 1.11-1.43) and had a greater number of outpatient visits. From 1990-1991 to 2000-2001, IBD cases experienced a significant decrease in the likelihood of an outpatient surgical visit relative to non-IBD controls (P < .05), and for those cases who were hospitalized, CD cases tended to be less likely than UC cases to experience IBD-specific inpatient surgery (P < .07). Of the 1987-1988 incidence cohort, 80% of admissions that occurred during the follow-up period were during the first 5 years after diagnosis. CONCLUSIONS: In 2000-2001, health care utilization continued to be higher in IBD versus controls and CD versus UC; however, the gap in costly service utilization appeared to narrow between the latter pair.
Authors: Angela Rocchi; Eric I Benchimol; Charles N Bernstein; Alain Bitton; Brian Feagan; Remo Panaccione; Kevin W Glasgow; Aida Fernandes; Subrata Ghosh Journal: Can J Gastroenterol Date: 2012-11 Impact factor: 3.522
Authors: Petra A Golovics; Laszlo Lakatos; Michael D Mandel; Barbara D Lovasz; Zsuzsanna Vegh; Zsuzsanna Kurti; Istvan Szita; Lajos S Kiss; Tunde Pandur; Peter L Lakatos Journal: World J Gastroenterol Date: 2015-06-21 Impact factor: 5.742
Authors: Michael D Kappelman; Carol Q Porter; Joseph A Galanko; Sheryl L Rifas-Shiman; Daniel A Ollendorf; Robert S Sandler; Jonathan A Finkelstein Journal: Inflamm Bowel Dis Date: 2011-01 Impact factor: 5.325
Authors: Manie Juneja; Leonard Baidoo; Marc B Schwartz; Arthur Barrie; Miguel Regueiro; Michael Dunn; David G Binion Journal: Dig Dis Sci Date: 2012-02-23 Impact factor: 3.199
Authors: Thomas Cars; Björn Wettermark; Robert Löfberg; Irene Eriksson; Johan Sundström; Mikael Lördal Journal: J Crohns Colitis Date: 2016-01-05 Impact factor: 9.071
Authors: Ruth Ann Marrie; Lawrence Elliott; James Marriott; Michael Cossoy; James Blanchard; Aruni Tennakoon; Nancy Yu Journal: Neurology Date: 2014-08-01 Impact factor: 9.910
Authors: Stefan D Holubar; Rajesh Pendlimari; Edward V Loftus; James P Moriarty; Dirk Larson; Megan O'Byrne; John H Pemberton; Robert R Cima Journal: Dis Colon Rectum Date: 2012-12 Impact factor: 4.585
Authors: Emily K Wright; Michael A Kamm; Peter Dr Cruz; Amy L Hamilton; Kathryn J Ritchie; Sally J Bell; Steven J Brown; William R Connell; Paul V Desmond; Danny Liew Journal: World J Gastroenterol Date: 2016-04-14 Impact factor: 5.742